Gene · 23345
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analyses of mitophagy-related genes and mitophagy-related lncRNAs for patients with ovarian cancer. | BMC Womens Health | 2024 | 38218807 | PubTator, text mining | PubMed |
| Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma. | PeerJ | 2024 | 38213773 | PubTator, text mining | PubMed |
| Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis. | Cancer Cell Int | 2024 | 38200479 | PubTator, text mining | PubMed |
| Association of endometriosis with Sjögren's syndrome: Genetic insights (Review). | Int J Mol Med | 2024 | 38186322 | PubTator, text mining | PubMed |
| Development and validation of a novel lysosome-related LncRNA signature for predicting prognosis and the immune landscape features in colon cancer. | Sci Rep | 2024 | 38182713 | PubTator, text mining | PubMed |
| Nuclear membrane protein SUN2 promotes replication of flaviviruses through modulating cytoskeleton reorganization mediated by NS1. | Nat Commun | 2024 | 38177122 | PubTator, text mining | PubMed |
| Unraveling the genetic landscape of undiagnosed cerebellar ataxia in Brazilian patients. | Parkinsonism Relat Disord | 2024 | 38145611 | PubTator, text mining | PubMed |
| Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer. | Noncoding RNA Res | 2024 | 38075203 | PubTator, text mining | PubMed |
| miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma. | Cancer Sci | 2024 | 38050664 | PubTator, text mining | PubMed |
| Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer. | Transl Oncol | 2024 | 38000147 | PubTator, text mining | PubMed |
| Enhancer-driven 3D chromatin domain folding modulates transcription in human mammary tumor cells. | Life Sci Alliance | 2024 | 37989525 | PubTator, text mining | PubMed |
| Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study. | Life Sci Alliance | 2024 | 37918965 | PubTator, text mining | PubMed |
| Co-mutation of TP53 and TTN is Correlated with the Efficacy of Immunotherapy in Lung Squamous Cell Carcinoma. | Comb Chem High Throughput Screen | 2024 | 37904553 | PubTator, text mining | PubMed |
| Integrating bulk and single-cell data to predict the prognosis and identify the immune landscape in HNSCC. | J Cell Mol Med | 2024 | 37882107 | PubTator, text mining | PubMed |
| Tislelizumab plus nimotuzumab is effective against recurrent or metastatic oral squamous cell carcinoma among patients with a performance status score ≥ 2: a retrospective study. | Front Oncol | 2023 | 38293699 | PubTator, text mining | PubMed |
| The pathogenesis of blepharospasm. | Front Neurol | 2023 | 38274886 | PubTator, text mining | PubMed |
| Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A2-2 in Human Prostate Cancer Cells. | Mar Drugs | 2023 | 38248645 | PubTator, text mining | PubMed |
| Integration of multi-omics technologies for molecular diagnosis in ataxia patients. | Front Genet | 2023 | 38239855 | PubTator, text mining | PubMed |
| Biallelic SOX8 Variants Associated With Novel Syndrome With Myopathy, Skeletal Deformities, Intellectual Disability, and Ovarian Dysfunction. | Neurol Genet | 2023 | 38235364 | PubTator, text mining | PubMed |
| Prognostic signature of colorectal cancer based on uric acid-related genes. | Heliyon | 2023 | 38213580 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23345/papers?page=8